Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Question on a potential merger...

Re: pautaotzu/milestone

posted on Jan 06, 2008 05:43PM

But do you believe TPL is looking out for us shareholders? 

 

It is not the responsibility of TPL to look out for PTSC shareholders, that lies squarely with the BOD.

 

As to your scenario of 6 entities holding 210 million shares, I'd look to the SEC to protect shareholders, Rule 405 of Regulation C under the Securities Act.

 

 

 

Be well

Share
New Message
Please login to post a reply